Introduction
In the rapidly evolving field of nanomedicine, innovative nanocarrier systems have emerged as a transformative approach for enhancing tumor targeting and therapeutic efficacy. These advanced systems leverage smart designs—such as stimuli-responsive materials, biomimetic coatings, and multifunctional architectures—to overcome biological barriers, improve tumor accumulation, and minimize off-target toxicity. This Special Issue invites cutting-edge research exploring novel strategies in nanocarrier development. We welcome contributions on, but not limited to, the following themes:
1. Stimuli-Responsive Nanocarriers
Light-, pH-, or enzyme-triggered drug release systems for precision therapy.
Theranostic platforms integrating imaging and controlled drug delivery.
2. Biomimetic and Biohybrid Nanocarriers
Cell membrane-coated nanoparticles for immune evasion and homologous targeting.
Extracellular vesicle (EV)-based delivery systems for natural tumor tropism.
3. Multifunctional and Combinatorial Nanosystems
Co-delivery of chemotherapeutics, nucleic acids (siRNA/miRNA), and immunomodulators.
Nanoplatforms combining photothermal, photodynamic, and chemo-therapies.
Keywords
Nanocarriers, Tumor Targeting, Stimuli-Responsive, Biomimetic, Drug Delivery, Cancer Therapy
Sub-topics
- Stimuli-responsive carriers (pH/light/enzyme-triggered release)
- Biomimetic systems (cell membrane coatings, extracellular vesicles)
- Multifunctional platforms (combined chemo/immuno/phototherapy)
